Skip to main content
Helixmith Co., Ltd logo

Helixmith Co., Ltd — Investor Relations & Filings

Ticker · 084990 ISIN · KR7084990001 KO Manufacturing
Open in API
Filings indexed 508 across all filing types
Latest filing 2020-10-16 Capital/Financing Update
Country KR South Korea
Listing KO 084990

About Helixmith Co., Ltd

https://www.helixmith.com/

Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a '증권신고서(지분증권)' (Securities Registration Statement for Equity Securities) filed by Helixmith. It details a capital increase (rights offering) including schedules, pricing, and risk factors. This is a formal regulatory filing required for public offerings of securities. It is not a report publication announcement (RPA) because it contains the full content of the registration statement, nor is it a simple earnings release. It falls under the category of regulatory filings for capital raising.
2020-10-16 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a capital increase (유상증자결정) filed by Helixmith Co., Ltd. It details the terms of a rights offering, including subscription dates, pricing methods, and share allocation procedures. This type of filing, which details changes to capital structure and financing activities, falls under the 'Capital/Financing Update' category.
2020-10-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements of major shareholders (Kim Sun-young and related parties) in Helixmith. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-10-12 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Capital Increase Decision' (유상증자결정) for Helixmith Co., Ltd. It details the amendment of dates and terms for a rights offering (paid-in capital increase), including subscription periods, payment dates, and listing dates. This falls under the category of announcements regarding new share issues and capital structure changes.
2020-10-07 Korean
투자판단관련주요경영사항(근위축성 측삭경화증(ALS, 루게릭병) 치료제(Engensis: VM202) 임상 2a상 최종 프로토콜 제출 완료(임상 개시))
Legal Proceedings Report Classification · 95% confidence The document is a regulatory filing from a Korean company (Helixmith) regarding a material business event, specifically the submission of a final protocol for a Phase 2a clinical trial for a drug (Engensis/VM202) to the US FDA. This type of disclosure is a standard regulatory announcement for material corporate events. Since it does not fit into specific categories like M&A, dividends, or financial reports, and is a formal regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2020-10-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details changes in share ownership by a major shareholder (Kim Sun-young) and related parties, including reasons for changes such as the cancellation of gifts and stock collateral loan repayments. This type of filing is a standard regulatory disclosure for significant shareholding changes, which falls under the 'Major Shareholding Notification' category.
2020-09-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.